Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-05

Clinical Trial Update: STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial at Indiana University is evaluating the safety and tolerability of lacosamide in patients with painful chronic pancreatitis, including …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

Sponsor: Indiana University | Conditions: Chronic Pain, Chronic Pain Syndrome | Phase 1 | Status: RECRUITING